Holen Sie sich die Stockscreener-App
73.05
0.34%
0.21
Schlusskurs vom Vortag:
$72.84
Offen:
$72.51
24-Stunden-Volumen:
697.90K
Relative Volume:
0.45
Marktkapitalisierung:
$8.86B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
29.94
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
+4.32%
1M Leistung:
+16.02%
6M Leistung:
+3.61%
1J Leistung:
+7.90%
1-Tages-Spanne:
$72.26
$73.52
1-Wochen-Bereich:
$70.18
$73.63
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
73.09 | 8.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
847.45 | 103.77B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
364.32 | 70.46B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
206.16 | 48.55B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.47 | 829.29M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
New Two-Volume Book UNJUST GAGGLE OF GAVELS Exposes Corruption in Oklahoma Medical Laboratory Industry - Markets Financial Content
What moving averages say about Henry Schein Inc.2025 Growth vs Value & Technical Pattern Based Buy Signals - newser.com
Henry Schein to Participate in Upcoming Investor Conference in December - The Globe and Mail
Henry Schein (Nasdaq: HSIC) at Piper Sandler Healthcare Conference Dec 2; webcast - Stock Titan
Chart based exit strategy for Henry Schein Inc.July 2025 Market Mood & Community Consensus Stock Picks - newser.com
Has Henry Schein Inc. found a price floorMarket Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Henry Schein at Stifel 2025 Healthcare Conference: Strategic Initiatives and Growth - Investing.com Nigeria
Key metrics from Henry Schein Inc.’s quarterly dataJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Transcript : Henry Schein, Inc. Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11 - MarketScreener
Will Henry Schein Inc. rebound enough to break evenQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
The Bull Case For Henry Schein (HSIC) Could Change Following Launch of AI-Powered Impact Panel Integration - simplywall.st
Will earnings trigger a reversal in Henry Schein Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - newser.com
Henry Schein (HSIC) Receives a Hold from UBS - The Globe and Mail
Tools to assess Henry Schein Inc.’s risk profile2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
Applying sector rotation models to Henry Schein Inc.Risk Management & Weekly High Conviction Ideas - newser.com
What candlestick patterns are forming on Henry Schein Inc.2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Henry Schein Inc. Stock Rises Monday, Still Underperforms Market - 富途牛牛
Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too? - The Motley Fool
Henry Schein Inc. stock volume spike explainedJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Will Henry Schein Inc. stock split again soonWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
What risks investors should watch in Henry Schein Inc. stockQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Henry Schein signals over $200M operating income improvement opportunity as BOLD+1 and KKR partnership advance - MSN
Henry Schein Inc. (HSIC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock - sharewise.com
Henry Schein (HSIC): Evaluating Valuation After Strong Q3 Results and Upgraded Guidance - simplywall.st
Using flow based indicators on Henry Schein Inc.Weekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
J.P. Morgan Sticks to Its Buy Rating for Henry Schein (HSIC) - The Globe and Mail
Jim Cramer on Henry Schein: “I Think It’s a Good Stock” - Insider Monkey
JPMorgan Chase & Co. Reduces Stake in Henry Schein Inc. - GuruFocus
Henry Schein rises after lifting 2025 guidance - MSN
Australia Dental Diagnostics and Surgical Equipment Market: Analysis of Key Trends and Innovations (2025-2033) Featuring Danaher, Straumann, Henry Schein and More - Yahoo Finance
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
Chipotle Is ‘Too Expensive,’ Cramer Says; Buy This Plane MakerBloom Energy (NYSE:BE), Boeing (NYSE:BA) - Benzinga
Will Henry Schein Inc. stock attract more institutional investorsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
Day 5 of Gains Streak for Henry Schein Stock with 16% Return (vs. 4.1% YTD) [11/5/2025] - Trefis
Can Henry Schein Inc. stock hit analyst price targetsStop Loss & Long-Term Safe Investment Ideas - newser.com
How Henry Schein Inc. stock performs during Fed tightening cycles2025 Short Interest & Community Verified Swing Trade Signals - Fundação Cultural do Pará
Published on: 2025-11-06 00:07:48 - newser.com
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Henry Schein Inc-Aktie (HSIC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
2.56%
1.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):